Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
335.6 USD | +0.27% | +4.70% | -26.70% |
May. 02 | Cigna sees strong annual profit on lower costs, pharmacy benefit strength | RE |
Apr. 26 | Deutsche Bank Adjusts Price Target on Humana to $341 From $355 | MT |
Financials (USD)
Sales 2024 * | 114B | Sales 2025 * | 116B | Capitalization | 40.44B |
---|---|---|---|---|---|
Net income 2024 * | 1.8B | Net income 2025 * | 2.33B | EV / Sales 2024 * | 0.4 x |
Net Debt 2024 * | 5.32B | Net Debt 2025 * | 4.75B | EV / Sales 2025 * | 0.39 x |
P/E ratio 2024 * |
22.2
x | P/E ratio 2025 * |
17
x | Employees | 67,600 |
Yield 2024 * |
1.12% | Yield 2025 * |
1.19% | Free-Float | 60.52% |
Latest transcript on Humana Inc.
1 day | +0.27% | ||
1 week | +4.70% | ||
Current month | +11.09% | ||
1 month | +5.14% | ||
3 months | -9.37% | ||
6 months | -31.94% | ||
Current year | -26.70% |
Managers | Title | Age | Since |
---|---|---|---|
Bruce Broussard
CEO | Chief Executive Officer | 61 | 11-11-30 |
Susan Diamond
DFI | Director of Finance/CFO | 50 | 05-12-31 |
Timothy Huval
ADM | Chief Administrative Officer | 57 | 12-11-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Brad Smith
BRD | Director/Board Member | 60 | 22-08-31 |
Kurt Hilzinger
CHM | Chairman | 63 | 03-06-30 |
Karen Katz
BRD | Director/Board Member | 67 | 19-09-22 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
2.30% | 0 M€ | +4.88% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 335.6 | +0.27% | 1,340,172 |
24-05-09 | 334.7 | +3.25% | 1,977,618 |
24-05-08 | 324.1 | -0.15% | 1,500,216 |
24-05-07 | 324.6 | +1.69% | 1,072,329 |
24-05-06 | 319.2 | -0.41% | 1,420,369 |
Delayed Quote Nyse, May 10, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-26.70% | 40.44B | |
-2.59% | 472B | |
+14.34% | 125B | |
+16.34% | 98.97B | |
+4.82% | 41.51B | |
-1.86% | 20.78B | |
-25.95% | 2.65B | |
-20.67% | 1.31B | |
-13.87% | 407M |
- Stock Market
- Equities
- HUM Stock